tissue factor VIIa inhibitors (BioCryst)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nametissue factor VIIa inhibitors (BioCryst)
Drug Alias Nameblood clotting modulators (BioCryst)Factor VIIa inhibitors (BioCryst)angina therapy (BioCryst)BCX-3891BCX-3898 +[6] 
ClassificationSmall molecules
Mechanisms of ActionTissue factor inhibitorsFactor VIIa modulatorsBlood clotting modulators
TargetsCoagulation factor VIITissue factor
Therapy Area/IndicationsThrombosisAngina PectorisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocryst Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsThrombosisAngina PectorisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A